LUCID DIAGNOSTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.82 USD | -5.64% |
|
+18.34% | -41.84% |
| 05-13 | Transcript : Lucid Diagnostics Inc., Q1 2024 Earnings Call, May 13, 2024 | |
| 05-13 | Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Lucid Diagnostics Inc.
67bdb788a.yIkcRaEEny89rKaYrXl9xXBOVPmTATkuYQrwfohymDc.jLEsIPZh8EVr9crPlDofhDkEJJvpcHxhMTqkE_k_zXy4zCp1lmGpblnjxQ~609147ca07e603a64eed5273584c43d5
Upcoming events on Lucid Diagnostics Inc.
Past events on Lucid Diagnostics Inc.
| 13/05/2024 13:30 | Q1 2024 Earnings Call |
| 13/05/2024 13:00 | Q1 2024 Earnings Release |
| 11/04/2024 16:00 | Needham Virtual Healthcare Conference - Fireside Chat |
| 26/03/2024 12:30 | Business Update Call |
| 25/03/2024 21:30 | Q4 2023 Earnings Release |
| 13/12/2023 15:00 | Investor Day |
| 17/11/2023 | Association for Molecular Pathology Meeting |
| 16/11/2023 15:00 | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
| 14/11/2023 13:30 | Q3 2023 Earnings Call |
| 13/11/2023 22:40 | Q3 2023 Earnings Release |
| 15/08/2023 13:30 | Business Update Call |
| 09/08/2023 16:30 | Canaccord Genuity Growth Conference |
| 21/06/2023 16:00 | Annual General Meeting |
| 16/05/2023 13:30 | Business Update Call |
| 15/05/2023 23:21 | Q1 2023 Earnings Release |
| 20/04/2023 16:00 | Needham Healthcare Conference |
| 14/03/2023 12:30 | Business Update Call - Fourth Quarter Results |
| 13/03/2023 22:21 | Q4 2022 Earnings Release |
| 17/11/2022 16:00 | Canaccord Genuity CG MedTech, Diagnostics and Digital Health & Services Forum |
| 14/11/2022 21:40 | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,50 0,60 -17% | 0,38 0,70 -45.88% | 2,43 2,46 -1.16% | 5,44 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -27,4 -19,7 -39.4% | -54,2 -52,6 -3.11% | -46,0 -48,9 5.87% | -38,8 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -27,4 -20,5 -33.68% | -56,2 -54,7 -2.61% | -48,5 -48,0 -1.03% | -42,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -28,1 -23,1 -21.46% | -56,2 -55,7 -0.85% | -52,7 -53,1 0.76% | -45,4 |
|
Net income Million USD | Released Forecast Spread | -8,28 | -28,1 -22,7 -23.64% | -56,2 -54,8 -2.43% | -52,7 -53,3 1.26% | -44,5 |
|
EPS USD | Released Forecast Spread | -0,59 | -1,51 -1,37 -10.22% | -1,55 -1,54 -0.98% | -1,26 -1,26 0.32% | -0,99 |
| Announcement Date | 22/09/21 | 28/03/22 | 14/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,19 0,45 -58.42% | 0,00 0,64 - | 0,08 0,43 -82.12% | 0,11 0,38 -70.51% | 0,45 0,23 94.59% | 0,16 0,61 -74.1% | 0,78 0,79 -1.21% | 1,04 1,06 -1.47% | 1,00 1,05 -4.33% | 1,22 | 1,45 | 1,78 | 1,63 | 2,23 |
|
EBITDA Million USD | Released Forecast Spread | -12,2 -10,1 -21.25% | -13,9 -10,9 -27.41% | -13,8 -12,2 -12.99% | -14,3 -12,6 -13.6% | -15,7 -10,6 -48.39% | -10,7 -11,5 7.3% | -13,6 -9,50 -42.63% | -10,8 -10,1 -7.43% | -10,2 -9,93 -2.44% | -9,30 | -9,40 | -9,47 | -9,33 | -9,77 |
|
EBIT Million USD | Released Forecast Spread | -12,8 -10,6 -20.42% | -14,6 -12,6 -16.3% | -14,3 -13,4 -7.28% | -14,9 -14,0 -6.46% | -14,3 -13,1 -9.09% | -11,6 -13,2 12.41% | -11,1 -11,1 0.08% | -11,5 -11,1 -3.53% | -10,8 -11,4 5.01% | -10,6 | -10,7 | -10,8 | -11,1 | -10,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,3 -11,1 -10.81% | -14,6 -12,6 -16.37% | -14,3 -14,2 -0.81% | -14,9 -14,4 -3.43% | -16,2 -14,3 -13.35% | -11,4 -13,8 17.33% | -14,2 -11,3 -26.11% | -10,8 -11,2 3.63% | -10,6 -11,5 7.96% | -10,8 | -11,0 | -11,2 | -11,4 | -11,4 |
|
Net income Million USD | Released Forecast Spread | -12,3 -10,6 -15.49% | -14,6 -12,6 -16.3% | -14,3 -14,4 0.01% | -14,9 -14,0 -6.46% | -16,2 -13,2 -23.23% | -11,4 -13,6 16.59% | -14,2 -11,6 -22.52% | -10,8 -11,5 5.74% | -18,1 -11,7 -54.41% | -10,6 | -10,8 | -11,0 | -11,8 | -11,5 |
|
EPS USD | Released Forecast Spread | -0,35 -0,29 -19.66% | -0,41 -0,36 -13.89% | -0,39 -0,40 1.68% | -0,40 -0,38 -5.26% | -0,40 -0,34 -19.4% | -0,27 -0,32 15.63% | -0,34 -0,27 -24.77% | -0,25 -0,26 3.1% | -0,40 -0,27 -49.25% | -0,23 | -0,23 | -0,22 | -0,23 | -0,21 |
| Announcement Date | 11/05/22 | 15/08/22 | 14/11/22 | 14/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 25/03/24 | 13/05/24 | - | - | - | - | - |
More events
Past sector events for Lucid Diagnostics Inc.
| 15/05/2024 07:00 | IMPLANTICA AG: Q1 2024 Earnings Release |
| 14/05/2024 | ASAHI INTECC CO., LTD.: Q3 2024 Earnings Release |
| 08/05/2024 17:20 | CHEMOMETEC A/S: Q3 2024 Sales and Revenue Release - Trading Statement |
| 07/05/2024 21:05 | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 06/05/2024 21:09 | SI-BONE, INC.: Q1 2024 Earnings Release |
| 06/05/2024 21:05 | SHOCKWAVE MEDICAL: Q1 2024 Earnings Release |
| 02/05/2024 13:30 | IRADIMED CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | NOVOCURE LIMITED: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LUCD Stock
- Calendar Lucid Diagnostics Inc.
